Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-18
2000-12-12
Low, Christopher S. F.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514279, 514300, 514359, 514365, 514367, 514408, 514423, 548146, 548152, 548200, 548201, 548400, 548452, 548469, 560312, 562623, C07D20900, C07D27504
Patent
active
061599832
ABSTRACT:
A composition in unit dosage form for the inhibition, prevention or treatment of inflammatory bowel disease comprising an effective amount of a compound having the formula: ##STR1## and a pharmaceutically acceptable carrier therefor. Also disclosed is a method for the inhibition, prevention or treatment of inflammatory bowel disease comprising administering to a human or non-human mammal in need thereof an effective amount of a compound having the formula: ##STR2##
REFERENCES:
patent: 5322961 (1994-06-01), Bergeron, Jr.
patent: 5367113 (1994-11-01), Bergeron, Jr.
patent: 5840739 (1998-11-01), Bergeron et al.
Kato, et al., "Synthesis and Antihypertensive Activity of 5-(2-hydroxyphenyl)-1-3-mercaptopropionyl)-2-pyrrolidinecarboxylic Acids" Chem. Pharm. Bull., 1985, 33(11), 4836-46.
Bergereon, et al., "The Desferrithiocin Pharmacophore" J. Med. Chem., 1994, 37, 1411-17.
Clarke Dennis P.
Gupta Anish
Low Christopher S. F.
University of Florida
LandOfFree
Method and composition for treatment of inflammatory bowel disea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for treatment of inflammatory bowel disea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for treatment of inflammatory bowel disea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-217962